Christophe Arbet-Engels insider trades

Open-market stock purchases and sales by Christophe Arbet-Engels, Chief Medical Officer at Altimmune, Inc, from SEC Form 4 filings since Feb 10, 2020.

Recent trades

DateStockTradeValue
Oct 1, 2026ALT Altimmune, IncSold (not open market)$35K
Oct 1, 2026ALT Altimmune, IncBought (not open market)—

Companies traded

  • ALT Altimmune, Inc: other filings, last Oct 1, 2026
  • XFOR X4 Pharmaceuticals, Inc: 1 sale, last Feb 12, 2025
  • MLND Millendo Therapeutics, Inc: other filings, last May 25, 2020

Get free alerts when Christophe Arbet-Engels files a new trade →